AtriCure, Inc.·4

May 3, 4:03 PM ET

Dahlquist Karl S. 4

4 · AtriCure, Inc. · Filed May 3, 2023

Insider Transaction Report

Form 4
Period: 2023-05-01
Dahlquist Karl S.
Chief Legal Officer
Transactions
  • Sale

    Common Stock

    2023-05-01$44.83/sh4,417$198,01436,319 total
Footnotes (2)
  • [F1]These shares were sold pursuant to a 10b5-1 trading plan adopted on February 24, 2023.
  • [F2]This transaction was executed in multiple trades at prices ranging from $44.31 to $45.45 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file
  • 4
    wf-form4_168314416777718.xmlPrimary

    FORM 4